Opening stock page...
Fetching company snapshot, pricing, and intelligence.
Intelligence coverage: 65%
Basic profile, financials, and market data are shown below. Deep research is building in the background.
AI confidence 70% · refreshes every 15s during session
Nutex Health Inc. shows decelerating business momentum based on AlphaOS pipeline evidence.
Why it matters: Revenue -14% YoY in Q2 FY2026.
3 signals not yet derived from pipeline evidence
What it means for the thesis — synthesis, not a raw event feed.
Pipeline evidence · 4d ago
NUTX's AlphaOS Signals
Upgrade to Pro for validated historical pattern analysis on NUTX.
Free accounts see more of this; Premium sees all of it.
Reported figures for Nutex Health Inc. — research only, not investment advice.
Updated
What happened recently for Nutex Health Inc. (NUTX) — events, not interpretation.
Research & analysis only — not investment advice.
Investment snapshot
NUTX's AI investment thesis
Upgrade to Premium for NUTX's full multi-agent investment thesis.
Free accounts see more of this; Premium sees all of it.
Unified data coverage and cross-signal highlights — market, SEC, earnings, opportunity
Strengthen intelligence
Latest price
$208.82
Market cap
$1.43B
Profitable
Yes
Revenue $216.49M
Net income
$46.81M
FY Aug 29, 2026
Loading Wall Street consensus…
Loading earnings intelligence…
Building technical intelligence snapshot — check back shortly.
Loading market context…
No price history. Sync market data to load charts.
Loading SEC filing intelligence…
No filings ingested yet.
Investment Snapshot above is the primary AlphaOS analysis for Nutex Health Inc. — structured signals and evidence from proprietary pipelines, not an encyclopedia overview.
Research & analysis only — not investment advice. Price, charts, and filings are above.
Follow Nutex Health Inc. through AlphaOS's knowledge graph — themes, peers, beneficiaries, earnings, and research answers.
Connected companies and research pages from the AlphaOS knowledge graph.